Ontology highlight
ABSTRACT: Background
Gain-of-function (GOF) mutations in the human signal transducer and activator of transcription 1 (STAT1) manifest in immunodeficiency and autoimmunity with impaired TH17 cell differentiation and exaggerated responsiveness to type I and II interferons. Allogeneic bone marrow transplantation has been attempted in severely affected patients, but outcomes have been poor.Objective
We sought to define the effect of increased STAT1 activity on T helper cell polarization and to investigate the therapeutic potential of ruxolitinib in treating autoimmunity secondary to STAT1 GOF mutations.Methods
We used in vitro polarization assays, as well as phenotypic and functional analysis of STAT1-mutated patient cells.Results
We report a child with a nove
SUBMITTER: Weinacht KG
PROVIDER: S-EPMC5482293 | biostudies-literature | 2017 May
REPOSITORIES: biostudies-literature